<ѻý>What Happens When All the Great Doctors Are Gone?ѻý> In commemoration of the late Elihu (Eli) Estey, MD Oct 13, 2021
<ѻý>Almost Half of Breast Cancer Patients Use Cannabis, Survey Findsѻý> Common reasons for use include pain, anxiety, nausea, and insomnia Oct 12, 2021
<ѻý>Christiane Amanpour's Ovarian Cancer and the Importance of Early Detectionѻý> Renowned reporter calls on women to advocate for themselves Oct 11, 2021
<ѻý>Ibrutinib-Rituximab Wins Out in Waldenstrom's Macroglobulinemiaѻý> Risk of disease progression or death reduced by 75% versus rituximab alone Oct 11, 2021
<ѻý>Case: VEGFR Inhibition in Merkel Cell Carcinoma Patientѻý> Disease stabilized after post-chemotherapy progression of the aggressive neuroendocrine cancer Oct 11, 2021
<ѻý>Nurse Killed in Times Squareѻý> Veteran oncology nurse was knocked over by fleeing burglar Oct 11, 2021
<ѻý>What's the Best Way to Treat Femur Breaks From Bone Metastases?ѻý> No difference in outcomes between long-stem hemiarthroplasty and intramedullary nailing Oct 10, 2021
<ѻý>Pediatric Sarcoma Patients Face Late Amputation Risk Decades Laterѻý> Study finds about 18% required amputation long after initial limb salvage surgery Oct 09, 2021
<ѻý>Take Sarcoma Research Based on Registry Data With a Grain of Saltѻý> Many studies using SEER/NCDB registries often generated disparate outcomes Oct 08, 2021
<ѻý>No Benefit for Longer-Duration Antibiotic Prophylaxis After Limb Salvageѻý> Surgical site infections similar versus shorter-duration prophylactic IV regimen Oct 08, 2021
<ѻý>Antibiotic Could Thwart Costly Sarcoma Surgery Complicationѻý> Benefit seen for adding "anaerobic coverage" to standard perioperative antibiotic prophylaxis Oct 07, 2021
<ѻý>Standard of Care Hard to Beat in HER2-Negative Breast Cancerѻý> Swapping letrozole for fulvestrant, in combination with palbociclib, did not improve PFS Oct 07, 2021
<ѻý>Can the Death Rattle Be Silenced?ѻý> Randomized trial says yes, but results may be challenging to put into practice Oct 05, 2021
<ѻý>Women With Very Dense Breasts Benefit From MRI Screeningѻý> Dutch researchers recommend screening with MRI every 4 years Oct 01, 2021
<ѻý>The Cost of Blood Platelets Is About to Surgeѻý> FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
<ѻý>Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancerѻý> Results from docetaxel-based study appear applicable to paclitaxel, nab-paclitaxel Sep 29, 2021
<ѻý>Immunotherapy Combo Fails to Boost Survival in Limited-Disease SCLCѻý> No PFS or OS improvement with consolidation nivolumab-ipilimumab after standard treatment Sep 29, 2021
<ѻý>Improved DFS, but No OS Boost, With Chemo in CRC With Liver Metastasesѻý> Longer disease-free survival did not mean longer overall survival for these patients Sep 28, 2021
<ѻý>What's Behind the Racial Differences in Women's Cancer Screening?ѻý> Existing medical conditions and social factors are likely driving gaps, researchers found Sep 24, 2021
<ѻý>FDA Issues Orders Clarifying Rules for Marketing Sunscreensѻý> But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
<ѻý>Another Checkpoint Inhibitor Misses Mark in Ovarian Cancerѻý> No OS or PFS benefit with nivolumab versus chemotherapy for platinum-resistant disease Sep 24, 2021
<ѻý>Radiation or Surgery in Early Lung Cancer: Does It Make a Difference?ѻý> Ablative radiation still noninferior to VATS after longer follow-up Sep 24, 2021
<ѻý>How Many Deaths Will New Cigarette Warnings Prevent?ѻý> Modeling study comes up with big numbers Sep 24, 2021
<ѻý>Fully Automated Capsule Endoscopy Feasible for Gastric Examsѻý> Minimally invasive, magnetically controlled capsule comparable to conventional endoscopy Sep 23, 2021
<ѻý>Checkpoint Inhibitors Whiff in Head and Neck Cancer Trialsѻý> Avelumab, nivolumab-ipilimumab, pembrolizumab miss endpoints in separate studies Sep 23, 2021
<ѻý>Top Science From the World Conference on Lung Cancerѻý> In this podcast, we examine some of the most important studies presented at this year's meeting Sep 23, 2021 podcast
<ѻý>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻý> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻý>Study Finds More Later-Stage CRC Diagnoses During Pandemicѻý> Japanese registry data reveals increase in stage III colorectal cancer, drops in earlier disease Sep 22, 2021
<ѻý>Survey Says: Support Is Lacking for Cancer's Lingering Effectsѻý> Survivors report dissatisfaction with long-term support Sep 22, 2021
<ѻý>Angiogenesis Inhibitor Slows Extrapancreatic Neuroendocrine Tumorsѻý> Almost 7-month increase in median PFS with addition of axitinib to endocrine therapy Sep 21, 2021
<ѻý>Transarterial Radioembolization Slows Progression of CRC With Liver Metsѻý> Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
<ѻý>Androgen-Targeting Combos Show Promise in Prostate Cancerѻý> Trials extend survival in hormone-sensitive disease Sep 21, 2021
<ѻý>Bifunctional Protein Shows Promise in HPV-Related Cancersѻý> Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
<ѻý>Sunitinib Effective in Very Rare Neuroendocrine Tumorѻý> The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
<ѻý>Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBCѻý> KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
<ѻý>ADC Makes a Case for Role in Metastatic HER2-Positive Breast Cancerѻý> Improved progression-free survival in previously treated disease with trastuzumab duocarmazine Sep 20, 2021
<ѻý>Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancerѻý> MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
<ѻý>Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancerѻý> More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
<ѻý>Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanomaѻý> Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
<ѻý>Practice-Changing Study in Advanced Cervical Cancerѻý> Improved PFS, OS with pembrolizumab and chemo with or without bevacizumab Sep 18, 2021